Massachusetts Medicaid Program Covers Pear Therapeutics Prescription Digital Therapeutics For Addiction Treatment

On November 9, 2021, the Massachusetts Medicaid program (MassHealth) added two Pear Therapeutics, Inc. prescription digital therapeutics (PDTs) — reSET® and reSET-O® — to the November 2021 MassHealth Drug List Summary Update. Both reSET and reSET-O have been authorized by the U.S. Food and Drug Administration (FDA) for treatment of addiction disorder and opioid use disorder, respectively. Effective November 1, 2021, MassHealth is covering reSET® and reSET-O® for MassHealth members in addiction treatment. The PDTs will be paid for through MassHealth’s Pharmacy Online Processing System (POPS) and do not require prior authorization. MassHealth has about 2 million . . .